APO RESEARCH · REPORT
Natamycin
Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.
Product & engineering
Understand the product.
Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.
Selected research
Industry Research
Natamycin Industry Research Report 2026
Market perspective
Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.
Global Natamycin key players include Danisco, DSM, VGP, Handary, AMTECH BIOTECH, etc. Global top five players hold a share about 50%.
North America is the largest market, with a share about 35%, followed by Europe and China, having a total share about 35 percent.
Read the full market overview
In terms of product, the segment includes Glucose-based, Lactose-based, Sodium chloride-based. And in terms of application, the application includes Food Industry, Medical, etc.
Report Scope
This report quantifies the global Natamycin market in terms of revenue (US$ million) and, where applicable, sales volume (MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/MT) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Natamycin Market by Company
Danisco
DSM
VGP
Handary
AMTECH BIOTECH
Silver-Elephant
Lanzhou Weiri
Langfang Meihua
Zhengzhou New Frey
Chihon
Jiaozuo Joincare
Beijing Oriental Rada
Pucheng Lifecome
Natamycin Segment by Type
Glucose-based
Lactose-based
Sodium chloride-based
Natamycin Segment by Application
Food
Medical
Others
Natamycin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Natamycin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Natamycin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Natamycin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Natamycin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Natamycin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Natamycin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Glucose-based
- Lactose-based
- Sodium chloride-based
Applications
- Food
- Medical
- Others
Companies covered
- Danisco
- DSM
- VGP
- Handary
- AMTECH BIOTECH
- Silver-Elephant
- Lanzhou Weiri
- Langfang Meihua
- Zhengzhou New Frey
- Chihon
- Jiaozuo Joincare
- Beijing Oriental Rada
- Pucheng Lifecome
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Natamycin Market Size (2021-2032)
- 2.2.2 Global Natamycin Sales (2021-2032)
- 2.2.3 Global Natamycin Market Average Price (2021-2032)
- 2.3 Natamycin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Glucose-based
- 2.3.3 Lactose-based
- 2.3.4 Sodium chloride-based
- 2.4 Natamycin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Food
- 2.4.3 Medical
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Natamycin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Natamycin Sales (MT) of Manufacturers (2021-2026)
- 3.3 Global Natamycin Revenue of Manufacturers (2021-2026)
- 3.4 Global Natamycin Average Price by Manufacturers (2021-2026)
- 3.5 Global Natamycin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Natamycin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Natamycin, Product Type & Application
- 3.8 Global Manufacturers of Natamycin, Established Date
- 3.9 Global Natamycin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Danisco
- 4.1.1 Danisco Company Information
- 4.1.2 Danisco Business Overview
- 4.1.3 Danisco Natamycin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Danisco Natamycin Product Portfolio
- 4.1.5 Danisco Recent Developments
- 4.2 DSM
- 4.2.1 DSM Company Information
- 4.2.2 DSM Business Overview
- 4.2.3 DSM Natamycin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 DSM Natamycin Product Portfolio
- 4.2.5 DSM Recent Developments
- 4.3 VGP
- 4.3.1 VGP Company Information
- 4.3.2 VGP Business Overview
- 4.3.3 VGP Natamycin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 VGP Natamycin Product Portfolio
- 4.3.5 VGP Recent Developments
- 4.4 Handary
- 4.4.1 Handary Company Information
- 4.4.2 Handary Business Overview
- 4.4.3 Handary Natamycin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Handary Natamycin Product Portfolio
- 4.4.5 Handary Recent Developments
- 4.5 AMTECH BIOTECH
- 4.5.1 AMTECH BIOTECH Company Information
- 4.5.2 AMTECH BIOTECH Business Overview
- 4.5.3 AMTECH BIOTECH Natamycin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 AMTECH BIOTECH Natamycin Product Portfolio
- 4.5.5 AMTECH BIOTECH Recent Developments
- 4.6 Silver-Elephant
- 4.6.1 Silver-Elephant Company Information
- 4.6.2 Silver-Elephant Business Overview
- 4.6.3 Silver-Elephant Natamycin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Silver-Elephant Natamycin Product Portfolio
- 4.6.5 Silver-Elephant Recent Developments
- 4.7 Lanzhou Weiri
- 4.7.1 Lanzhou Weiri Company Information
- 4.7.2 Lanzhou Weiri Business Overview
- 4.7.3 Lanzhou Weiri Natamycin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Lanzhou Weiri Natamycin Product Portfolio
- 4.7.5 Lanzhou Weiri Recent Developments
- 4.8 Langfang Meihua
- 4.8.1 Langfang Meihua Company Information
- 4.8.2 Langfang Meihua Business Overview
- 4.8.3 Langfang Meihua Natamycin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Langfang Meihua Natamycin Product Portfolio
- 4.8.5 Langfang Meihua Recent Developments
- 4.9 Zhengzhou New Frey
- 4.9.1 Zhengzhou New Frey Company Information
- 4.9.2 Zhengzhou New Frey Business Overview
- 4.9.3 Zhengzhou New Frey Natamycin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Zhengzhou New Frey Natamycin Product Portfolio
- 4.9.5 Zhengzhou New Frey Recent Developments
- 4.10 Chihon
- 4.10.1 Chihon Company Information
- 4.10.2 Chihon Business Overview
- 4.10.3 Chihon Natamycin Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Chihon Natamycin Product Portfolio
- 4.10.5 Chihon Recent Developments
- 4.11 Jiaozuo Joincare
- 4.11.1 Jiaozuo Joincare Company Information
- 4.11.2 Jiaozuo Joincare Business Overview
- 4.11.3 Jiaozuo Joincare Natamycin Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Jiaozuo Joincare Natamycin Product Portfolio
- 4.11.5 Jiaozuo Joincare Recent Developments
- 4.12 Beijing Oriental Rada
- 4.12.1 Beijing Oriental Rada Company Information
- 4.12.2 Beijing Oriental Rada Business Overview
- 4.12.3 Beijing Oriental Rada Natamycin Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Beijing Oriental Rada Natamycin Product Portfolio
- 4.12.5 Beijing Oriental Rada Recent Developments
- 4.13 Pucheng Lifecome
- 4.13.1 Pucheng Lifecome Company Information
- 4.13.2 Pucheng Lifecome Business Overview
- 4.13.3 Pucheng Lifecome Natamycin Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Pucheng Lifecome Natamycin Product Portfolio
- 4.13.5 Pucheng Lifecome Recent Developments
5 Global Natamycin Market Scenario by Region
- 5.1 Global Natamycin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Natamycin Sales by Region: 2021-2032
- 5.2.1 Global Natamycin Sales by Region: 2021-2026
- 5.2.2 Global Natamycin Sales by Region: 2027-2032
- 5.3 Global Natamycin Revenue by Region: 2021-2032
- 5.3.1 Global Natamycin Revenue by Region: 2021-2026
- 5.3.2 Global Natamycin Revenue by Region: 2027-2032
- 5.4 North America Natamycin Market Facts & Figures by Country
- 5.4.1 North America Natamycin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Natamycin Sales by Country (2021-2032)
- 5.4.3 North America Natamycin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Natamycin Market Facts & Figures by Country
- 5.5.1 Europe Natamycin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Natamycin Sales by Country (2021-2032)
- 5.5.3 Europe Natamycin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Natamycin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Natamycin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Natamycin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Natamycin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Natamycin Market Facts & Figures by Country
- 5.7.1 South America Natamycin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Natamycin Sales by Country (2021-2032)
- 5.7.3 South America Natamycin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Natamycin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Natamycin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Natamycin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Natamycin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Natamycin Sales by Type (2021-2032)
- 6.1.1 Global Natamycin Sales by Type (2021-2032) & (MT)
- 6.1.2 Global Natamycin Sales Market Share by Type (2021-2032)
- 6.2 Global Natamycin Revenue by Type (2021-2032)
- 6.2.1 Global Natamycin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Natamycin Revenue Market Share by Type (2021-2032)
- 6.3 Global Natamycin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Natamycin Sales by Application (2021-2032)
- 7.1.1 Global Natamycin Sales by Application (2021-2032) & (MT)
- 7.1.2 Global Natamycin Sales Market Share by Application (2021-2032)
- 7.2 Global Natamycin Revenue by Application (2021-2032)
- 7.2.1 Global Natamycin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Natamycin Revenue Market Share by Application (2021-2032)
- 7.3 Global Natamycin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Natamycin Value Chain Analysis
- 8.1.1 Natamycin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Natamycin Production Mode & Process
- 8.2 Natamycin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Natamycin Distributors
- 8.2.3 Natamycin Customers
9 Global Natamycin Analyzing Market Dynamics
- 9.1 Natamycin Industry Trends
- 9.2 Natamycin Industry Drivers
- 9.3 Natamycin Industry Opportunities and Challenges
- 9.4 Natamycin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst